Authors
Latest:
Nivolumab Plus Talazoparib Does Not Induce Responses in Heavily Pretreated MelanomaNivolumab plus talazoparib did not produce RECIST-based tumor responses in heavily pretreated patients with unresectable or metastatic melanoma.
Latest:
Looking Ahead to the 2023 ACMS MeetingThe ACMS president and scientific program chair share opportunities to discover innovations in Mohs surgery during this weekend’s meeting.
Latest:
Gut Microbiome Can Affect Radiation Cancer TreatmentThe overgrowth of fungi could cause the immune system to stop fighting cancer, according to a study.
Latest:
Overcoming Treatment Barriers in Vitiligo: From Insurance Coverage to Patient AdherenceAndrew Alexis, MD, MPH, reviews the case of a 66-year-old woman who presented with depigmented patches and provides clinical insights on barriers typically encountered during the management of this condition.
Latest:
Hands-on Workshop Empowers Clinicians in Cosmetic DermatologyRobin Siperstein, MD, FAAD, shares practical tips in cosmetic dermatology at the 2024 SDPA Annual Summer Dermatology Meeting.
Latest:
Key Takeaways on the Management of Atopic DermatitisPanelists share parting advice and key takeaways on the optimal management of atopic dermatitis within the treatment landscape.
Latest:
Addressing Quality of Life Specifics Associated With Atopic Dermatitis and Skin of ColorZakiya Pressley Rice, MD, took a deep dive into how atopic dermatitis severity and increased rates of grade school absenteeism affect patients with skin of color during a recent Masterclasses in Dermatology meeting.
Latest:
Dermatologic differences in a diverse populationUnderstanding the difference in biology and clinical presentations of cutaneous conditions in different skin types is critical for health care professionals to treat a diverse population.
Latest:
Lloyd Miller, MD, PhD: Delving Into JNJ-2113 Data for Plaque PsoriasisMiller, Vice President, Immunodermatology Disease Area Leader, Johnson & Johnson, spoke with Dermatology Times about recently published data supporting JNJ-2113's potential in this indication.
Latest:
The Importance of Collaboration Between Mohs Surgeons and UrologistsCaleb Kovell, MD and Junqian Zhang, MD demonstrated how teaming up increases the likelihood for positive patient outcomes in Mohs cases on the genitalia and perianal region.
Latest:
Key Takeaways For the Management of Plaque PsoriasisExperts in dermatology share closing thoughts on the management of plaque psoriasis.
Latest:
Frontline Forum Part 4: Improving Basal Cell Carcinoma ManagementIn the final part of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, review 4 real-world clinical cases of BCC and the treatments they utilized.
Latest:
SFA-002 Shows Promise in Early Clinical Trial Psoriasis CohortsStefan Weiss, MD, MBA, explains next steps for the oral treatment after the completion of phase 1b enrollment.
Latest:
Deucravacitinib: A Year in ReviewAs deucravacitinib surpasses its 1-year milestone since approval, clinicians continue to monitor its real-world performance among patients.
Latest:
BCC Patient Case ImpressionsSherrif F. Ibrahim, MD, PhD, and Vishal Patel, MD, FAAD, FACMS, provide initial impressions of the case and discuss the use of immune checkpoint inhibitors.
Latest:
SPROUT Trial Highlights Benefits of Apremilast for Pediatric PsoriasisThe trial showcased the continued efficacy of apremilast, with 2-year data on the forefront.
Latest:
An Increase in Skin Cancer Calls for an Increase in Treatment OptionsTo address the increased rates of skin cancer while keeping unique patient needs top of mind, there is a pressing need to increase options for treatment.
Latest:
The Dx and Rx of Congenital Malalignment Syndrome in ChildrenCongenital malalignment syndrome is a nail disorder caused by the lateral rotation of the nail matrix.
Latest:
Evan Rieder, MD: Equipping Patients With Tools for Skin AcceptanceFollowing this week's Science of Skin media roundtable hosted by AbbVie, panelist and dual-board certified dermatologist and psychiatrist Evan Rieder, MD, discusses the relationship between chronic skin conditions and mental health.
Latest:
Tailoring Aesthetic Treatments for Patients With Skin of ColorOmer Ibrahim, MD, discusses the nuances of aesthetic procedures for patients with skin of color and the importance of tailored treatments, safety, and improved clinician education.
Latest:
Select Medical Software Based on Your Practice’s Life Cycle StageThough providers probably can use any type of medical software, the financial resources they are able to invest in medical solutions differ significantly based on the type of practice.
Latest:
Addressing Cutaneous Blisters and Chronic Bullous Disorders With Megan Noe, MD, MPH, MSCEMegan Noe, MD, MPH, MSCE, reviews best practices for treating patients with cutaneous blisters and managing chronic bullous disorders.
Latest:
Q&A: Late-Breaking REMIX-1 and REMIX-2 Data Demonstrated Efficacy of Remibrutinib in Chronic Spontaneous UrticariaAllergist immunologist Giselle Mosnaim, MD, recently spoke with Dermatology Times to discuss late-breaking phase 3 REMIX-1 and REMIX-2 data presented at the American Academy of Allergy, Asthma, and Immunology Annual Meeting.
Latest:
In Skin Cancer, Immunotherapy May Lead to Chronic EffectsResearch showed that many patients with skin cancer who had been treated using immunotherapy, such as immune checkpoint inhibition, experienced chronic side effects.
